I have no medical experience, however, Roche are recruiting a Patient Safety (Pharmacovigilance) Partner, based in Melbourne.
This role could just be a coincidence, however, I thought it was very interesting.
It is my understanding Patient Safety (Pharmacovigilance) professionals often work with new biotech partners to ensure effective collaboration and adherence to safety standards. When entering into a partnership, especially in the field of biotechnology, these professionals play a critical role in establishing and maintaining robust pharmacovigilance practices.
Key Roles and Activities:
Due Diligence:Conduct thorough due diligence to assess the biotech partner’s pharmacovigilance capabilities and compliance with regulatory requirements.- Evaluate the partner’s existing safety data, reporting systems, and risk management practices.
Establishing Agreements:
Develop and negotiate pharmacovigilance agreements (PVAs) that define roles, responsibilities, and expectations for both parties.Ensure that the agreements include provisions for data sharing, adverse event reporting, and regulatory compliance.System Integration:Work on integrating pharmacovigilance systems and databases to facilitate seamless data exchange and reporting.- Ensure that the biotech partner’s systems are compatible and secure, meeting industry standards for data integrity and confidentiality.
Training and Support:
Provide training and support to the biotech partner’s staff on pharmacovigilance processes, regulatory requirements, and safety reporting.Share best practices and guidelines to ensure that all parties are aligned in their approach to patient safety.Safety Data Exchange:
Establish mechanisms for the timely and accurate exchange of safety data, including adverse event reports and periodic safety update reports (PSURs).- Ensure that both parties have access to the necessary tools and platforms for effective data management.Risk Management:Collaborate with the biotech partner to develop and implement risk management plans (RMPs) tailored to the specific products and therapeutic areas.
- Conduct joint benefit-risk assessments and safety signal detection activities.Regulatory Compliance:Ensure that the biotech partner complies with all relevant local and international pharmacovigilance regulations.
- Prepare for regulatory inspections and audits by maintaining comprehensive and up-to-date documentationCommunication:Facilitate open and transparent communication channels between the partnering organisations.
- Regularly update all stakeholders on safety issues, regulatory changes, and other relevant developments.
In summary, Patient Safety (Pharmacovigilance) professionals are crucial in ensuring that new biotech partnerships are established and maintained with a strong focus on patient safety and regulatory compliance. Their expertise helps to build a robust framework for monitoring and managing drug safety, benefiting both the partners and the patients they serve.
Just wondering if anyone else thinks this is relevant?
- Forums
- ASX - By Stock
- Ann: Deborah Ambrosini appointed as CFO & Company Secretary
I have no medical experience, however, Roche are recruiting a...
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
|
|||||
Last
8.7¢ |
Change
0.003(3.57%) |
Mkt cap ! $78.43M |
Open | High | Low | Value | Volume |
8.4¢ | 8.7¢ | 8.4¢ | $72.99K | 855.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 452608 | 8.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.7¢ | 398595 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 452608 | 0.084 |
3 | 212500 | 0.083 |
2 | 106250 | 0.080 |
2 | 125578 | 0.079 |
2 | 30620 | 0.078 |
Price($) | Vol. | No. |
---|---|---|
0.087 | 398595 | 1 |
0.088 | 400000 | 1 |
0.089 | 135000 | 2 |
0.090 | 794374 | 5 |
0.092 | 50000 | 1 |
Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online